Planta Med 2007; 73(3): 257-261
DOI: 10.1055/s-2007-967126
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

In Vitro and In Vivo Antiallergic Effects of Glycyrrhiza glabra and Its Components

Yong-Wook Shin1 , Eun-Ah Bae1 , Bomi Lee1 , Seung Ho Lee2 , Jeong Ah Kim2 , Yeong-Shik Kim3 , Dong-Hyun Kim1
  • 1College of Pharmacy, Kyung Hee University, Dongdaemun-ku, Seoul, Korea
  • 2College of Pharmacy, Yeugnam University, Kyongsan, Kyungsangbuk-do, Korea
  • 3Institute of Natural Product, Seoul National University, Jongro-Ku, Seoul, Korea
Further Information

Publication History

Received: October 4, 2006

Accepted: January 15, 2007

Publication Date:
28 February 2007 (online)

Abstract

Licorice (Glycyrrhiza glabra L., Leguminosae) is frequently used in traditional medicine to treat inflammatory and allergic diseases. In this study, the main components (glycyrrhizin, 18β-glycyrrhetinic acid, isoliquiritin, and liquiritigenin) were isolated from licorice, and their anti-allergic effects, such as antiscratching behavior and IgE production-inhibitory activity, were evaluated both in vitro and in vivo. Liquiritigenin and 18β-glycyrrhetinic acid most potently inhibited the degranulation of RBL-2H3 cells induced by IgE with the antigen (DNP-HSA) and rat peritoneal mast cells induced by compound 48/80. Liquiritigenin and 18β-glycyrrhetinic acid potently inhibited the passive cutaneous anaphylactic reaction as well as the scratching behavior in mice induced by compound 48/80. These components inhibited the production of IgE in ovalbumin-induced asthma mice but liquiritigenin had little effect. This suggests that the antiallergic effects of licorice are mainly due to glycyrrhizin, 18β-glycyrrhetinic acid, and liquiritigenin, which can relieve IgE-induced allergic diseases such as dermatitis and asthma.

References

  • 1 Wuthrich B. Epidemiology of the allergic diseases: are they really on the increase?.  Int Arch Allergy Appl Immunol. 1989;  90 3-10.
  • 2 Stevens R L, Austen K F. Recent advances in the cellular and molecular biology of mast cells.  Immunol Today. 1989;  10 381-6.
  • 3 Bruhns P, Fremont S, Daeron M. Regulation of allergy by Fc receptors.  Curr Opin Immunol. 2005;  17 662-9.
  • 4 Nicoloff B J. The cytokine network in psoriasis.  Arch Dermatol. 1991;  127 871-84.
  • 5 Mitre E, Nutman T B. Basophils, basophilia and helminth infections.  Chem Immunol Allergy. 2006;  90 141-56.
  • 6 Schafer-Korting M, Schmid M H, Korting H C. Topical glucocorticoids with improved risk-benefit ratio. Rationale of a new concept.  Drug Safety. 1996;  14 375-85.
  • 7 Sakuma S, Higashi Y, Sato N, Sasakawa T, Sengoku T, Ohkubo Y. et al . Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system (Comparison with steroids).  Int Immunopharmacol. 2001;  1 1219-26.
  • 8 Simons F E. The antiallergic effects of antihistamines (H1-receptor antagonists).  J Allergy Clin Immunol. 1992;  90 705-15
  • 9 Bielory L. Complementary and alternative interventions in asthma, allergy, and immunology.  Ann Allergy Asthma Immunol. 2004;  93 S45-54.
  • 10 Liut H M, Akiyama T, Sugimoto N, Maitani T. Isolation and identification of main constituents in an enzymatically hydrolysed licorice extract sweetener.  Food Addit Contam. 2001;  18 281-4.
  • 11 Cao Y, Wang Y, Ji C, Ye J. Determination of liquiritigenin and isoliquiritigenin in Glycyrrhiza uralensis and its medicinal preparations by capillary electrophoresis with electrochemical detection.  J Chromatogr A. 2004;  1042 03-9.
  • 12 Kanazawa M, Satomi Y, Mizutani Y, Ukimura O, Kawauchi A, Sakai T. et al . Isoliquiritigenin inhibits the growth of prostate cancer.  Eur Urol. 2003;  43 580-6
  • 13 Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr H W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus.  Lancet. 2003;  361 2045-6.
  • 14 Kakegawa H, Matsumoto H, Satoh T. Inhibitory effects of some natural products on the activation of hyaluronidase and their anti-allergic actions.  Chem Pharm Bull. 1992;  40 1439-42.
  • 15 Ram A, Mabalirajan U, Das M, Bhattacharya I, Dinda A K, Gangal S V. et al . Glycyrrhizin alleviates experimental asthma in mice.  Int Immunopharmacol. 2006;  6 1468-77.
  • 16 Sasaki H, Takei M, Kobayashi M, Pollard R B, Suzuki F. Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients.  Pathobiology. 2002 - 2003;  70 229-36.
  • 17 Tamir S, Eizenberg M, Somjen D, Izrael S, Vaya J. Estrogen-like activity of glabrene and other constituents isolated from licorice root.  J Steroid Biochem Mol Biol. 2001;  78 291-8.
  • 18 Kim D H, Hong S W, Kim B T, Bae E A, Park H Y, Han M J. Biotransformation of glycyrrhizin by human intestinal bacteria and its relation to biological activities.  Arch Pharm Res. 2000;  23 172-7.
  • 19 Hatano T, Kagawa H, Yasuhara T, Okuda T. Two new flavonoids and other constituents in licorice root: their relative astringency and radical scavenging effects.  Pharm Bull. 1988;  36 2090-7.
  • 20 Fu B, Li H, Wang X, Lee F S, Cui S. Isolation and identification of flavonoids in licorice and a study of their inhibitory effects on tyrosinase.  J Agric Food Chem. 2005;  53 7408-14.
  • 21 Hattori M, Sakamoto T, Yamagishi T, Sakamoto K, Konishi K, Kobashi K. et al . Metabolism of glycyrrhizin by human intestinal flora. II. Isolation and characterization of human intestinal bacteria capable of metabolizing glycyrrhizin and related compounds.  Pharm Bull. 1985;  33 210-7.
  • 22 Choo M K, Park E K, Han M J, Kim D H. Antiallergic activity of ginseng and its ginsenoside.  Planta Med. 2003;  69 518-22.
  • 23 Sugimoto Y, Umakoshi K, Nojiri N, Kamei C. Effect of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice.  Eur J Pharmacol. 1998;  351 1-5.
  • 24 Friedman E S, LaNatra N, Stiller M J. NSAIDs in dermatologic therapy: review and preview.  J Cutan Med Surg. 2002;  6 449-59.
  • 25 Belvisi M G, Hele D J. Soft steroids: a new approach to the treatment of inflammatory airways diseases.  Pulm Pharmacol Ther. 2003;  16 321-5.
  • 26 Akagi M, Mio M, Tasaka K. Histamine release inhibition and prevention of the decrease in membrane fluidity induced by certain antiallergic drugs: analysis of the inhibitory mechanism of NCO-650.  Agents Actions. 1983;  13 49-56.
  • 27 Yim J S, Kim Y S, Moon S K, Cho K H, Bae H S, Kim J J. et al . Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora.  Pharm Bull. 2004;  27 1580-3.
  • 28 Akao T, Hayashi T, Kobashi K, Kanaoka M, Kato H, Kobayashi M. et al . Intestinal bacterial hydrolysis is indispensable to absorption of 18 beta-glycyrrhetinic acid after oral administration of glycyrrhizin in rats.  Pharm Pharmacol. 1994;  46 135-7.
  • 29 Yi H, Nakashima I, Isobe K. Enhancement of nitric oxide production from activated macrophages by glycyrrhizin.  J Chin Med. 1996;  24 271-8.
  • 30 Akamatsu H, Komura J, Asada Y, Niwa Y. Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation.  Med. 1991;  57 119-21.

Prof. Dr. Dong-Hyun Kim

College of Pharmacy

Kyung-Hee University

1 Hoegi

Dongdaemun-ku

Seoul 130-701

Korea

Fax: +82-2-957-5030

Email: dhkim@khu.ac.kr

    >